U.S,Ca:18006380796

Contact Us

Get 30% Free Customization on This Report

Published Date: August, 2017

Acute Lymphocytic Leukemia Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023


Request Discount Enquire Before Buying

A recent report published by Infinium Global Research on acute lymphocytic leukemia market provides in depth analysis of segments and sub-segments in global as well as regional acute lymphocytic leukemia market. The study also highlights the impact of drivers, restraints and macro indicators on the global and regional acute lymphocytic leukemia market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global acute lymphocytic leukemia market. According to report the global acute lymphocytic leukemia market is projected to grow at a CAGR of 5.7% over the forecast period of 2017-2023.

Acute Lymphocytic Leukemia (ALL) is also known as acute lymphoblastic leukemia, is a cancer of white blood cell or bone marrow, which occurs due to overproduction and accumulation of cancerous white blood cell, known as lymphoblasts. ALL is an acute form of leukemia which majorly affects the lymphoid system, blood and bone marrow. This type of leukemia is more dominant in infants, however, it can be also diagnosed in adults. The common symptoms of ALL a patient exhibits are weakness, tiredness, dizziness, fever, shortness of breath, frequent infections, bruising, and bleeding. Globally, the growing awareness about ALL among the consumers has primarily driven the demand for drugs and treatment of acute lymphocytic leukemia.

The growth in acute lymphocytic leukemia market is primarily driven by unmet healthcare needs coupled with innovative therapies. Moreover, provision for orphan drugs is majorly contributing to the growth of this market. However, High cost of production, adverse effect of drugs and entry of generics are considered to be the major restraining factors that are likely to hinder the growth of this market over the forecast period. Yet, the global acute lymphocytic leukemia market is expected to present several opportunities to the leading players in the market over the forecast period, due to growing unmet healthcare needs and minimal competition.

 

Segment Covered

The report on global acute lymphocytic leukemia market covers segments such as, therapeutics, route of administration and molecule type. On the basis of therapeutics the global acute lymphocytic leukemia market is categorized into existing drugs and pipeline drugs. Existing drugs are further sub segmented into CALGB 8811 regimen, hyper CVD regimen, linker regimen, nucleoside regimen and on Casper; Pipeline drugs are further sub segmented into margibo, graspa, inotuzumab ozogamicin. On the basis of route of administration the global acute lymphocytic leukemia market is categorized into oral and parental. On the basis of molecule type the global acute lymphocytic leukemia market is categorized into biologics, small molecule, ambulatory clinics and home healthcare.

 

Geographic Coverage

The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2015-2023.

 

Figure: Global Acute Lymphocytic Leukemia Market by Region, CAGR % 2017-2023

Global Acute Lymphocytic Leukemia Market

 

The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China.  The APAC region is projected to experience a growth at a CAGR of x.x% over the period of 2017-2023.

 

Companies Profiled:

The report provides profiles of the companies in the global acute lymphocytic leukemia market such as, ERYTECH Pharma, Talon Therapeutic, Inc, GlaxoSmithKline plc, Sigma-Tau Pharmaceuticals, Inc, Genzyme Corporation, Amgen, Bristol-Myers Squibb, Novartis, Juno Therapeutics, Inc. and Celgene Corporation.

 

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the global acute lymphocytic leukemia market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of acute lymphocytic leukemia market.

Moreover, the study highlights current market trends and provides forecast from 2017-2023. We also have highlighted future trends in the acute lymphocytic leukemia market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. This report will help manufacturers, suppliers and distributors of the acute lymphocytic leukemia market to understand the present and future trends in this market and formulate their strategies accordingly.

The Infinium Advantages

Analyst Support

Get free analyst support for the queries before and post purchasing report.

Customer Satisfaction

Be assured of 100% customer satisfaction about the research and get 24X7 customer support.

400% Growth

Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.

sign up for our newsletter